Official websites use. Share sensitive information only on official, secure websites. All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publisher and the editor s.
The appearance of advertisements in the journal is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor s disclaim responsibility for any injury to persons or property resulting form any ideas, methods, instructions or products referred to in the content or advertisements. Back Volumes and Single Issues: Information on availability and prices of single print issues and print or electronic back volumes can be obtained from Customer Service at aboservice karger.
For customers in Germany: Please contact your local bookstore or S. For customers in all other countries: Please contact your bookshop or S. Karger AG. Publisher: S. Printed on acid-free and non-aging paper ISO The ratio of young to old people in Germany is shifting more and more towards the elderly.
Because risk of most disease rises with age, an aging society will be confronted with a higher burden of diseases. This might have also an impact on the supply with blood. Because of missing data on age, sex and disease-specific blood supply rates we used selected diseases or therapies as a proxy for blood supply. Based on sex- and age-specific rates and on official predictions of population figures, we did projections of absolute disease numbers and number of therapies.
Additionally we examined further data sources to estimate the current demand for blood supply. Blood supply is needed for therapy of many of the investigated diseases. Therefore, it can be assumed that future demand of blood will rise in a similar manner as the rising number of diseases. The projected developments describe an extraordinary challenge for the German health care system and in particular for transfusion medicine.
